| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $19.32 | $0.00 | Buy | 9 | 2026 |
#2 | WAY | United States | $18.57 | $1,099,278,000.00 | Strong Buy | 17 | 2023 |
#3 | CDE | United States | $17.47 | $709,598,000.00 | Strong Buy | 5 | 1994 |
#4 | VRRM | United States | $13.30 | $132,969,000.00 | Buy | 5 | 2016 |
#5 | TBPH | United States | $16.30 | $15,386,000.00 | Buy | 6 | 2013 |
#6 | EYE | United States | $17.37 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#7 | AMRX | United States | $11.95 | $0.00 | Strong Buy | 5 | 2018 |
#8 | BXMT | United States | $18.23 | $0.00 | Buy | 5 | 1998 |
#9 | KROS | United States | $10.15 | $243,864,000.00 | Buy | 7 | 2020 |
#10 | OPRX | United States | $5.06 | $109,429,000.00 | Strong Buy | 6 | 2008 |
#11 | HLMN | United States | $7.18 | $1,552,224,000.00 | Strong Buy | 5 | 2020 |
#12 | ALHC | United States | $16.18 | $3,948,719,000.00 | Buy | 8 | 2021 |
#13 | NMRK | United States | $14.33 | $3,294,024,000.00 | Buy | 5 | 2017 |
#14 | OMER | United States | $11.70 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#15 | WWW | United States | $15.33 | $1,874,300,000.00 | Buy | 10 | 2002 |
#16 | CERT | United States | $4.59 | $418,838,000.00 | Buy | 10 | 2020 |
#17 | ACRS | United States | $4.45 | $1,683,000.00 | Strong Buy | 5 | 2015 |
#18 | NRDS | United States | $8.08 | $836,600,000.00 | Buy | 5 | 2021 |
#19 | AMLX | United States | $12.86 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#20 | XNCR | United States | $11.07 | $125,576,000.00 | Buy | 9 | 2013 |
#21 | ADPT | United States | $12.77 | $276,976,000.00 | Strong Buy | 9 | 2019 |
#22 | AZTA | United States | $16.30 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#23 | ARVN | United States | $8.81 | $262,600,000.00 | Buy | 19 | 2018 |
#24 | STTK | United States | $6.00 | $1,000,000.00 | Buy | 7 | 2020 |
#25 | IMNM | United States | $19.85 | $6,941,000.00 | Strong Buy | 10 | 2020 |
#26 | CRVS | United States | $12.18 | $0.00 | Strong Buy | 6 | 2016 |
#27 | RLMD | United States | $6.30 | $13,070.00 | Strong Buy | 5 | 2012 |
#28 | REAL | United States | $9.43 | $692,845,000.00 | Buy | 8 | 2019 |
#29 | LXEO | United States | $4.73 | $654,000.00 | Strong Buy | 9 | 2023 |
#30 | CRTO | France | $16.30 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#31 | TARA | United States | $4.62 | $2,948,000.00 | Strong Buy | 5 | 2014 |
#32 | IMRX | United States | $4.91 | $0.00 | Strong Buy | 5 | 2021 |
#33 | ERAS | United States | $10.31 | $0.00 | Strong Buy | 12 | 2021 |
#34 | SLDB | United States | $6.55 | $8,094,000.00 | Strong Buy | 11 | 2017 |
#35 | RIVN | United States | $13.39 | $5,387,000,000.00 | Buy | 21 | 2021 |
#36 | SBH | United States | $11.82 | $3,701,424,000.00 | Buy | 6 | 2006 |
#37 | TRVI | United States | $13.47 | $0.00 | Strong Buy | 11 | 2019 |
#38 | RLAY | United States | $12.20 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#39 | ADCT | Switzerland | $3.16 | $81,357,000.00 | Strong Buy | 4 | 2019 |
#40 | MRBK | United States | $17.35 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#41 | ENTA | United States | $13.50 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#42 | RYN | United States | $19.91 | $484,485,000.00 | Buy | 4 | 1994 |
#43 | BHVN | United States | $8.54 | $0.00 | Buy | 14 | 2022 |
#44 | FHTX | United States | $3.84 | $30,909,000.00 | Strong Buy | 8 | 2020 |
#45 | RVLV | United States | $18.45 | $1,225,682,000.00 | Buy | 12 | 2018 |
#46 | VITL | United States | $8.26 | $759,444,000.00 | Buy | 11 | 2020 |
#47 | ORIC | United States | $7.94 | $0.00 | Strong Buy | 13 | 2020 |
#48 | FDMT | United States | $8.39 | $85,209,000.00 | Strong Buy | 7 | 2019 |
#49 | RGNX | United States | $5.65 | $10,393,000.00 | Strong Buy | 8 | 2015 |
#50 | ZNTL | United States | $3.65 | $0.00 | Buy | 5 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (May 19, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.